DUPONT CAPITAL MANAGEMENT CORP - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$151,052
+120.1%
1,319
+164.9%
0.01%
+133.3%
Q1 2023$68,639
-85.1%
498
-86.0%
0.00%
-86.4%
Q4 2022$459,361
-45.0%
3,545
-53.1%
0.02%
-56.0%
Q3 2022$835,000
+150.8%
7,554
+70.1%
0.05%
+212.5%
Q2 2022$333,000
-38.1%
4,440
+6.5%
0.02%
+33.3%
Q4 2019$538,000
+71.3%
4,1690.0%0.01%
+71.4%
Q3 2019$314,000
-59.9%
4,169
-19.2%
0.01%
-61.1%
Q2 2019$784,000
-9.2%
5,159
-28.8%
0.02%
-10.0%
Q1 2019$863,000
+50.3%
7,241
+37.6%
0.02%
+42.9%
Q4 2018$574,000
-32.5%
5,2640.0%0.01%
-26.3%
Q3 2018$850,000
+68.0%
5,264
+37.5%
0.02%
+58.3%
Q2 2018$506,000
+20.5%
3,827
-32.4%
0.01%
+20.0%
Q1 2018$420,000
-64.7%
5,663
-73.5%
0.01%
-63.0%
Q4 2017$1,189,000
+106.1%
21,369
+68.0%
0.03%
+107.7%
Q3 2017$577,000
+77.5%
12,722
+31.8%
0.01%
+85.7%
Q2 2017$325,000
+13.6%
9,6530.0%0.01%
+16.7%
Q1 2017$286,000
-37.4%
9,653
-42.0%
0.01%
-40.0%
Q4 2016$457,000
+50.3%
16,648
+15.5%
0.01%
+100.0%
Q3 2014$304,000
-15.3%
14,415
+19.8%
0.01%
-16.7%
Q2 2014$359,00012,0350.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Ikarian Capital, LLC 399,400$35,962,0005.36%
Avoro Capital Advisors LLC 3,125,000$281,406,0004.79%
Varenne Capital Partners 324,661$29,236,0004.34%
Evolutionary Tree Capital Management, LLC 96,695$8,707,0004.18%
Ally Bridge Group (NY) LLC 120,000$10,806,0003.78%
Casdin Capital, LLC 1,350,000$121,568,0003.43%
Ghost Tree Capital, LLC 100,000$9,005,0003.23%
GREAT POINT PARTNERS LLC 145,405$13,094,0002.91%
Camber Capital Management LP 825,000$74,291,0002.55%
Alpha DNA Investment Management LLC 17,522$1,577,0001.00%
View complete list of SAREPTA THERAPEUTICS INC shareholders